Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
-
VoxelSensors Brings a New Level of Empathic Abilities to Devices: PERCEPT Technology Allows Devices to Comprehend User Intentions to Enable Truly Immersive Experiences
-
Codere Online and Blip redefine online gaming in Mexico with innovative partnership
-
ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit
-
$150M Boost for Huntress Powers New Products in Escalating Fight to Secure Backbone of Global Economy
-
WOO Ecosystem hits milestone $1.6 billion 24-hour trading volume
-
Multitude SE - Managers' Transactions - Jokela
-
Avicanna to Present at the Life Science Investor Forum June 20th, 2024
-
Comstock Shareholder Update
-
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
-
The Cluster Yachting Monaco celebrates the 10th anniversary at the Yacht Club de Monaco
-
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
-
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
-
America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2024 Results
-
HPQ Silicon Welcomes Canada's Recognition of Silicon Metal as a Critical Mineral
-
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
-
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
-
Houston Firm Strengthens Tax & Risk Expertise with New Hires
-
Clubhouse Media Group, Inc. Announces Model and Comedian, Maya Spielman, Joins HoneyDrip.com
-
Vyluma Meets with FDA on Atropine Sulfate Ophthalmic Solution 0.01% Under Development to Treat Pediatric Myopia
-
Namib Minerals, an Established African Gold Producer, to Become Publicly Traded Through Business Combination With Hennessy Capital Investment Corp. VI
-
Super Hi Reports Unaudited Financial Results for the First Quarter of 2024
-
Aduro Clean Technologies Announces Closing of Non-Brokered Private Placement
-
Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders
-
BridgeBio Pharma Surpasses Interim Analysis Enrollment Target and Receives U.S. FDA Rare Pediatric Disease Designation for BBP-418, a Potential Treatment for Limb-girdle Muscular Dystrophy Type 2I/R9
-
Houston Firm Strengthens Tax & Risk Expertise with New Hires
-
The Habit Burger Grill Opens 11th Restaurant in New Jersey With Hamilton Drive-Thru Location
-
DeFi Technologies Subsidiary Valour Inc. Introduces World’s First and Only Yield Bearing Bitcoin (BTC) ETP in Collaboration with Core Foundation, to German Investors on Börse Frankfurt Offering Exp
-
Abaxx Announces Investor Call
-
Equinor ASA: Notifiable trading
-
Patagonia Gold Announces Advances in Calcatreu Permitting
-
O-I Glass to Invest $65 Million in Electrification and Decarbonization in Veauche, France
-
O-I Glass to Invest $65 Million in Electrification and Decarbonization in Veauche, France
-
Form 8.3 - Equals Group PLC
-
Preqin announces winners for 2024 Preqin Awards
-
Mesa Air Group Reports Second Quarter Fiscal 2024 Results
-
DSV, 1116 - SHARE BUYBACK IN DSV A/S
-
LuxUrban Hotels Issues Letter to Shareholders from Chief Executive Officer Robert Arigo
-
DAVIDsTEA Reports Financial Results for First Quarter of Fiscal 2024
-
Forsys Reports Results from Preliminary Leaching Test Work and Project Workplan at Norasa
-
Clene Presents Extended Survival Data Through 3.5 Years and New NfL Responder Results with CNM-Au8® 30 mg Treatment from the HEALEY ALS Platform Trial Open Label Extension at the 2024 ENCALS Meetin
-
EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
-
Standard Uranium Confirms Uranium Mineralization in Multiple Drill Holes at Atlantic Project; Provides Analytical Highlights from Winter Drill Program
-
LSL Pharma Group Completes the Acquisition of Virage Santé
-
Emergex Announces MHRA Approval of MIA (IMP) Manufacturing and Import Authorisation License
-
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
-
Ashland achieves certification by Fair Wage Network
-
One of the World’s Largest Loitering Munitions Providers Selects Mobilicom’s UAV Ground Control Station - Market Set to Reach $26 Billion
-
Dorman Products releases hundreds of new cost-saving and aftermarket-exclusive repair solutions
-
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
